APPLIED GENETIC TECHNOLOGIES CORP Quarterly Operating Income (Loss) in USD from Q3 2012 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Applied Genetic Technologies Corp quarterly/annual Operating Income (Loss) history and growth rate from Q3 2012 to Q3 2022.
  • Applied Genetic Technologies Corp Operating Income (Loss) for the quarter ending September 30, 2022 was -$17.3M, a 5.6% decline year-over-year.
  • Applied Genetic Technologies Corp Operating Income (Loss) for the twelve months ending September 30, 2022 was -$67.1M, a 12.2% decline year-over-year.
  • Applied Genetic Technologies Corp annual Operating Income (Loss) for 2022 was -$66.2M, a 13.2% decline from 2021.
  • Applied Genetic Technologies Corp annual Operating Income (Loss) for 2021 was -$58.5M, a 24.5% decline from 2020.
  • Applied Genetic Technologies Corp annual Operating Income (Loss) for 2020 was -$46.9M, a 979% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$67.1M -$17.3M -$919K -5.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 -$66.2M -$17.7M -$3.94M -28.6% Apr 1, 2022 Jun 30, 2022 10-K 2022-09-27
Q1 2022 -$62.2M -$13.6M +$905K +6.25% Jan 1, 2022 Mar 31, 2022 10-K 2022-09-27
Q4 2021 -$63.1M -$18.4M -$3.33M -22% Oct 1, 2021 Dec 31, 2021 10-K 2022-09-27
Q3 2021 -$59.8M -$16.4M -$1.36M -9.05% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$58.5M -$13.8M +$794K +5.45% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-27
Q1 2021 -$59.2M -$14.5M -$3.05M -26.6% Jan 1, 2021 Mar 31, 2021 10-K 2022-09-27
Q4 2020 -$56.2M -$15.1M -$6.19M -69.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-09-27
Q3 2020 -$50M -$15.1M -$3.07M -25.6% Jul 1, 2020 Sep 30, 2020 10-K 2022-09-27
Q2 2020 -$46.9M -$14.6M -$3.14M -27.4% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-23
Q1 2020 -$43.8M -$11.4M -$22.4M -204% Jan 1, 2020 Mar 31, 2020 10-K 2021-09-23
Q4 2019 -$21.4M -$8.93M -$4.26M -91.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-09-23
Q3 2019 -$17.1M -$12M -$12.7M -1686% Jul 1, 2019 Sep 30, 2019 10-K 2021-09-23
Q2 2019 -$4.35M -$11.4M -$4.66M -68.8% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-18
Q1 2019 $311K $11M +$18.7M Jan 1, 2019 Mar 31, 2019 10-K 2020-09-18
Q4 2018 -$18.4M -$4.67M +$1.57M +25.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-09-18
Q3 2018 -$20M $756K +$2.42M Jul 1, 2018 Sep 30, 2018 10-K 2020-09-18
Q2 2018 -$22.4M -$6.78M -$4.18M -161% Apr 1, 2018 Jun 30, 2018 10-K 2019-09-26
Q1 2018 -$18.2M -$7.7M -$7.1M -1183% Jan 1, 2018 Mar 31, 2018 10-K 2019-09-26
Q4 2017 -$11.1M -$6.24M -$8.62M -362% Oct 1, 2017 Dec 31, 2017 10-K 2019-09-26
Q3 2017 -$2.49M -$1.67M -$5.29M -146% Jul 1, 2017 Sep 30, 2017 10-K 2019-09-26
Q2 2017 $2.81M -$2.6M -$5.08M -204% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-11
Q1 2017 $7.89M -$600K -$2.37M -134% Jan 1, 2017 Mar 31, 2017 10-K 2018-09-11
Q4 2016 $10.3M $2.38M -$491K -17.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-09-11
Q3 2016 $10.7M $3.63M +$12.8M Jul 1, 2016 Sep 30, 2016 10-K 2018-09-11
Q2 2016 -$2.09M $2.49M +$10.5M Apr 1, 2016 Jun 30, 2016 10-K 2017-09-13
Q1 2016 -$12.6M $1.77M +$8.16M Jan 1, 2016 Mar 31, 2016 10-K 2017-09-13
Q4 2015 -$20.8M $2.87M +$7.57M Oct 1, 2015 Dec 31, 2015 10-K 2017-09-13
Q3 2015 -$28.3M -$9.21M -$3.8M -70.3% Jul 1, 2015 Sep 30, 2015 10-K/A 2017-09-08
Q2 2015 -$24.5M -$8.03M -$3.61M -81.5% Apr 1, 2015 Jun 30, 2015 10-K/A 2017-09-08
Q1 2015 -$20.9M -$6.39M -$3.13M -96% Jan 1, 2015 Mar 31, 2015 10-K/A 2017-09-08
Q4 2014 -$17.8M -$4.7M -$1.8M -61.9% Oct 1, 2014 Dec 31, 2014 10-K/A 2017-09-08
Q3 2014 -$16M -$5.41M -$3.44M -175% Jul 1, 2014 Sep 30, 2014 10-K/A 2017-09-08
Q2 2014 -$12.6M -$4.43M -$3.14M -244% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-10
Q1 2014 -$9.42M -$3.26M -$2.31M -243% Jan 1, 2014 Mar 31, 2014 10-K 2015-09-10
Q4 2013 -$7.11M -$2.91M -$2.11M -265% Oct 1, 2013 Dec 31, 2013 10-K 2015-09-10
Q3 2013 -$5M -$1.97M -$1.41M -251% Jul 1, 2013 Sep 30, 2013 10-K 2015-09-10
Q2 2013 -$3.59M -$1.29M Apr 1, 2013 Jun 30, 2013 10-K 2014-09-26
Q1 2013 -$951K Jan 1, 2013 Mar 31, 2013 10-K 2014-09-26
Q4 2012 -$796K Oct 1, 2012 Dec 31, 2012 10-K 2014-09-26
Q3 2012 -$560K Jul 1, 2012 Sep 30, 2012 10-K 2014-09-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.